Literature DB >> 15543587

Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.

P D Minor1, G Dunn, M E Ramsay, D Brown.   

Abstract

Excretion of live oral poliovaccine and molecular markers of increased virulence in the viruses isolated were examined in children who were either previously immunised with inactivated or live vaccine or were unimmunised. There appeared to be some effect of previous immunisation with either live or killed vaccine at the second dose of live vaccine. Where an effect was seen it took the form of reduced rates of excretion, shorter time periods of excretion and more rapid and complete reversion of the excreted virus. The data are consistent with the view that poliovirus is able to escape the immune pressure in the gut to some extent by improving its general fitness rather than direct evasion of immunity. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15543587     DOI: 10.1002/jmv.20250

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay.

Authors:  Devasena Gnanashanmugam; Meira S Falkovitz-Halpern; Anthony Dodge; Melanie Fang; Lisa J Wong; Melissa Esparza; Rebecca Hammon; Enrique E Rivas-Merelles; Jose I Santos; Yvonne Maldonado
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

2.  Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine.

Authors:  Sebastian Zurbriggen; Kurt Tobler; Carlos Abril; Sabine Diedrich; Mathias Ackermann; Mark A Pallansch; Alfred Metzler
Journal:  Appl Environ Microbiol       Date:  2008-07-18       Impact factor: 4.792

3.  Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Jong-Hoon Kim; Cara C Burns; Olen M Kew; M Steven Oberste; Ousmane M Diop; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-07       Impact factor: 4.000

4.  Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.

Authors:  Andrew J Macadam; Geraldine Ferguson; David M Stone; Janet Meredith; Sarah Knowlson; Ghazi Auda; Jeffrey W Almond; Philip D Minor
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient.

Authors:  John K Odoom; Zaira Yunus; Glynis Dunn; Philip D Minor; Javier Martín
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

6.  Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey.

Authors:  Jiawei Xu; Qing Wang; Shanshan Kuang; Rong Rong; Yuanyuan Zhang; Xiaojuan Fu; Wenge Tang
Journal:  Hum Vaccin Immunother       Date:  2021-03-24       Impact factor: 3.452

7.  Estimating the risk of re-emergence after stopping polio vaccination.

Authors:  Akira Sasaki; Yoshihiro Haraguchi; Hiromu Yoshida
Journal:  Front Microbiol       Date:  2012-05-21       Impact factor: 5.640

8.  A novel gamma radiation-inactivated sabin-based polio vaccine.

Authors:  Gregory J Tobin; John K Tobin; Elena K Gaidamakova; Taralyn J Wiggins; Ruth V Bushnell; Wai-Ming Lee; Vera Y Matrosova; Stephen J Dollery; Heather N Meeks; Diana Kouiavskaia; Konstantin Chumakov; Michael J Daly
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

9.  An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.

Authors:  Yong Zhang; Dongmei Yan; Shuangli Zhu; Yorihiro Nishimura; Xufang Ye; Dongyan Wang; Jaume Jorba; Hui Zhu; Hongqiu An; Hiroyuki Shimizu; Olen Kew; Wenbo Xu
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.